Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor More
Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor
Zanamivir- medication used to treat and prevent influenza caused by influenza A and B viruses.
Zanamivir; Relenza; 4-Guanidino-Neu5Ac2en; Zanamivir hydrate
Z Flu DPI, Virenza
(2R,3R,4S)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid
It is an neuraminidase inhibitor and antiviral agent, indicated for treatment of uncomplicated acute illness due to influenza A and B virus in adults and pediatric patients 7 years and older who have been symptomatic for no more than 2 days. Zanamivir has also been shown to significantly inhibit the human sialidases NEU3 and NEU2 in the micromolar range (Ki 3.7 +/-0.48 and 12.9+/-0.07 microM, respectively), which could account for some of the rare side effects of zanamivir.
10 mg twice daily for 5days as inhalation.
For the prevention and treatment of influenza A and B.
Swelling, itching, skin rashes, headache, nausea, vomiting, cough and bronchitis.
Hypersensitivity
Store at room temperature
332.3098
C12H20N4O7
139110-80-8
Zanamivir should not be prescribed to patients with lactose allergy, COPD, asthma and other airway disorders.
